Biocon-BBL Integration: Can It Unmask The Biosimilars Arm’s Intrinsic Worth?

 
• By Anju Ghangurde
  
Valuation
Biocon consolidating generics and biosimilars business (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Financing